<DOC>
	<DOCNO>NCT01451658</DOCNO>
	<brief_summary>Patients hepatocellular carcinoma esophageal varix bleed randomize undergo endoscopic ligation alone ( group A ) additive propranolol treatment ( group B ) stabilization first acute bleeding .</brief_summary>
	<brief_title>Endoscopic Treatment Alone Versus Combined Propranolol Endoscopic Treatment Acute Variceal Hemorrhage Patients With Hepatocellular Carcinoma</brief_title>
	<detailed_description>Esophageal variceal bleed characteristic high rebleeding rate mortality . Thanks recent advance treatment variceal bleed non-selective beta blocker ( NSBB ) add endoscopic ligation reduce rebleeding cirrhotic patient , rebleeding rate mortality mark reduction . However , hepatocellular carcinoma ( HCC ) distinct group characteristic poor prognosis patient portal hypertension compare liver cirrhosis . Therefore , investigator design study randomize patient HCC acute variceal bleed endoscopic treatment alone combination endoscopic treatment NSBB . This two year study .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>1. clinical diagnosis HCC 2. endoscopically proven acute variceal bleed 3. young 18 year old old 80 year old Had terminal illness major organ system , heart failure , kidney failure , COPD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Variceal bleeding</keyword>
	<keyword>portal hypertension</keyword>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>endoscopic variceal ligation</keyword>
	<keyword>non-selective beta-blocker</keyword>
	<keyword>rebleeding</keyword>
</DOC>